Neuropathic Clinical Trials

131 recruitingLast updated: May 13, 2026

There are 131 actively recruiting neuropathic clinical trials across 31 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Chicago, Illinois, United States, Miami, Florida, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Neuropathic Trials at a Glance

131 actively recruiting trials for neuropathic are listed on ClinicalTrialsFinder across 6 cities in 31 countries. The largest study group is Not Applicable with 60 trials, with the heaviest enrollment activity in Chicago, Miami, and Boston. Lead sponsors running neuropathic studies include Afyonkarahisar Health Sciences University, Centre Hospitalier Universitaire de Saint Etienne, and University Hospital, Clermont-Ferrand.

Browse neuropathic trials by phase

Treatments under study

About Neuropathic Clinical Trials

Looking for clinical trials for Neuropathic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neuropathic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neuropathic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 131 trials

Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated734 enrolled66 locationsNCT07231419
Recruiting

Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury

NeuropathySpinal Cord InjuriesPain, Neuropathic+1 more
University of Zurich300 enrolled1 locationNCT06443281
Recruiting
Not Applicable

rTMS Efficacy Coupled With Mirror Therapy

Neuropathic Pain
Centre Hospitalier Universitaire de Saint Etienne64 enrolled2 locationsNCT04867187
Recruiting
Not Applicable

Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function.

Neuropathic PainRehabilitation ExerciseSpinal Cord Stimulation (SCS)+2 more
Oslo University Hospital10 enrolled1 locationNCT07403331
Recruiting
Not Applicable

Non-invasive Personalized Transcranial Cortical Neurostimulation for Pain Relief

Drug-resistant Neuropathic Pain
Hospices Civils de Lyon50 enrolled1 locationNCT06209645
Recruiting
Not Applicable

Thalamic-Burst-DBS for Neuropathic Pain

Neuropathic PainCentral Post-stroke Pain
Insel Gruppe AG, University Hospital Bern20 enrolled1 locationNCT05204472
Recruiting
Phase 1Phase 2

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)
Florida A&M University20 enrolled1 locationNCT07298408
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated1,100 enrolled76 locationsNCT06628908
Recruiting
Not Applicable

Evaluation of the Clinical Efficacy and Mechanisms of Cord Plasma Eye Drops in the Treatment of Neuropathic Corneal Pain

Neuropathic PainCorneal Disease
Singapore Eye Research Institute20 enrolled1 locationNCT07566806
Recruiting
Phase 1Phase 2

Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)

Chronic Neuropathic Pain
Sangamo Therapeutics27 enrolled11 locationsNCT06980948
Recruiting
Phase 2

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated300 enrolled47 locationsNCT06619860
Recruiting
Phase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

painful peripheral neuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Diabetic Peripheral Neuropathic Pain (DPN)+1 more
University of Rochester190 enrolled7 locationsNCT06614322
Recruiting
Phase 2

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

diabetic neuropathic painChronic Low-back PainOsteoarthritis, Knee
Eli Lilly and Company10,000 enrolled64 locationsNCT05986292
Recruiting
Phase 2

Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap

Neuropathic PainNeuroma
Massachusetts General Hospital20 enrolled1 locationNCT06915662
Recruiting
Phase 1

A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic peripheral neuropathic pain
Shandong Suncadia Medicine Co., Ltd.168 enrolled2 locationsNCT07377721
Recruiting

Neuropathic Characteristics of Subacromial Pain Syndrome

central sensitizationSubacromial Pain SyndromeNeuropathic Pain
Izmir City Hospital82 enrolled1 locationNCT07057128
Recruiting
Phase 4

Low Dose Naltrexone for Pain in Patients With HIV

Human Immunodeficiency VirusChronic Neuropathic Pain
Emory University60 enrolled3 locationsNCT05537935
Recruiting

Characteristics of Persistent Pain Composition Following Total Hip or Knee Arthroplasty: a Descriptive Study

Survey and QuestionnairePain (Visceral, Somatic, or Neuropathic)Hip Arthroplasty Replacement+1 more
Rigshospitalet, Denmark100 enrolled1 locationNCT07110324
Recruiting
Not Applicable

Virtual Reality (VR) Self-Hypnosis Software

Musculoskeletal PainNeuropathic PainNeuralgia
Icahn School of Medicine at Mount Sinai25 enrolled1 locationNCT06398847
Recruiting
Not Applicable

Chronic Unilateral Lumbar Radicular Pain

Neuropathic Pain
Ain Shams University80 enrolled1 locationNCT06092749